Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment for hemophilia A or B without inhibitors - making it the first antitissue-factor pathway inhibitor to be allowed for the ...
Here's what you need to know about popular supplements Airborne and Emergen-C, including how well they work, safety ...
The San Francisco-based firm will use the proceeds to accelerate commercialization of its Intellisep rapid sepsis test.